The findings and conclusions in these presentations have not been formally disseminated by the Centers for Disease Control and Prevention and should not be construed to represent any agency determination or policy.

Clearwater
Wednesday, May 10, 2006: 10:00 AM-11:45 AM

C8: Current Issues in Genital Herpes and Human Papillomavirus Prevention

10:00 AMDoes clinical severity of genital herpes predict risk of transmission? Analysis of the Valacyclovir Transmission Study
H. Nina Kim, Anna Wald, Julia Harris, Jennifer L. Almekinder, Cathy Heitman, Lawrence Corey
10:15 AMSingle-day episodic treatment of recurrent genital herpes using famciclovir: Implications for public health practice
Gary A. Richwald, Peter A. Leone, Stephen Tyring, Kamal Hamed
10:30 AMEstimating the incidence of neonatal herpes infection in New York City, 1994-2003; implications for formulating a national case definition
Julia A. Schillinger, Ellen Klingler, Preeti Pathela, Anna Battat, Hwa-Gan Chang, Eric Friedenberg, Bonnie Kerker, Perry Smith, Susan Blank
10:45 AMConcordance in Decision Making for STD Vaccination Between Parents and Adolescents
Beth E. Juliar, Rita M. Bair, Gregory D. Zimet, Lynne A. Sturm, Rose M. Mays, Susan M. Perkins
11:00 AMEffect of a Cervical High-Risk Human Papillomavirus (HR-HPV) Diagnosis on Women's Sexuality in Los Angeles
Bita Amani, Pamina Gorbach, Angela Shin, Ross Cranston, Janet St. Lawrence, Peter Kerndt
11:15 AMPromoting General Awareness of HPV, its Link to Cancer and Genital Warts: A Social Marketing Approach
Allison L. Friedman, Eileen F. Dunne, Hilda Shepeard

The 2006 National STD Prevention Conference of CDC